VAM 2023 attendees have their say on the impact of BEST-CLI and BASIL-2 trials

As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and BASIL-2—attendees of the 2023 Vascular Annual Meeting (VAM) in National Harbor, Maryland (June 14–17) told Vascular Specialist how they see the two landmark trials shaping practice in years to come.


Please enter your comment!
Please enter your name here